AnxietyNCT07088367
Virtual Reality Meditation on Anxiety in Cancer Patients Receiving Chemotherapy
A study testing Virtual reality meditation and Virtual Reality Videos in people with Anxiety and Cancer, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
The main questions this study aims to answer are: Does VR meditation, delivered through virtual reality glasses and the MediboothVR application, effectively reduce anxiety in cancer patients during chemotherapy? Is there a meaningful difference in anxiety reduction between the VR intervention groups and the control… Read more about this study
- Who is it for?
- Ages 18 years and older
- What is being tested?
- Virtual reality meditation and Virtual Reality Videos
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 89 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Apr 2024to 1 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged 18 years or older,
- Sufficient communication ability to respond to study questions,
- Receiving outpatient treatment for at least three consecutive days with a confirmed cancer diagnosis,
- Scoring 40 or above on the State Anxiety Inventory (STAI-S), indicating moderate or higher anxiety levels,
- Voluntarily agreeing to participate in the study.
Who cannot join
- Inability to speak or understand Turkish,
- Being under contact isolation precautions,
- Presence of active eye discharge or visual impairment,
- History of seizures, epilepsy, or hypersensitivity to flashing lights,
- History of vertigo or motion sickness,
- Experiencing active nausea or vomiting,
Show all 14Show fewer
- Having wounds or dressings on the head or face that interfere with the use of a VR headset,
- Hearing impairment,
- Hypersensitivity of the face or scalp to light pressure,
- Diagnosis of psychiatric conditions that may affect participation (e.g., schizophrenia, severe psychosis),
- Diagnosis of recurrent or relapsed cancer,
- Scoring below 40 on the State Anxiety Inventory,
- Previous use of virtual reality applications,
- Prior experience with meditation practices.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Virtual Reality Meditation on Anxiety Management in Cancer Patients Receiving Chemotherapy: A Randomized Controlled Study
The main questions this study aims to answer are:
Does VR meditation, delivered through virtual reality glasses and the MediboothVR application, effectively reduce anxiety in cancer patients during chemotherapy?
Read more
Is there a meaningful difference in anxiety reduction between the VR intervention groups and the control group?
Researchers will compare two intervention groups using VR glasses-one with guided meditation and one with calming video content-to a control group receiving standard care, to see if there are differences in anxiety levels.
Participants will:
Be randomly assigned to one of three groups
Attend their scheduled chemotherapy sessions
Depending on group assignment, either:
Use VR glasses with the MediboothVR meditation app for 10 minutes daily
Use VR glasses to watch calming 360-degree nature videos for 10 minutes daily
Receive standard care with no VR use
All participants will complete anxiety questionnaires and have their vital signs recorded before and after each session.
Read the detailed description
This clinical trial includes three parallel groups: a VR meditation group, a VR video group, and a control group.
Participants in the VR meditation group will receive a 10-minute virtual reality (VR) guided meditation session on three consecutive days, between 10:00 AM and 12:00 PM. The sessions will be delivered using virtual reality glasses and the MediboothVR application. A different meditation video will be used each day.
The MediboothVR application is the first immersive virtual reality meditation app developed in Türkiye and is also the first to support the Turkish language. It provides audio-guided meditation in a 360-degree artificial environment through virtual reality glasses. Each meditation video lasts approximately 10 minutes. Sessions begin with a short period for environmental observation, followed by a journey sequence that transports the user to a dedicated meditation area. A silhouette then appears and delivers the guided meditation experience through structured audio.
Participants in the VR video group will also use virtual reality glasses for 10 minutes each day, over three consecutive days, during the same time frame. Instead of meditation, they will watch 360-degree calming nature videos. A different video will be shown each day to support relaxation through immersive visual content.
These videos were selected to promote relaxation and included high-definition panoramic visuals such as forests, oceans, waterfalls, and mountain landscapes. Each day, a different video was used to maintain novelty and reduce visual fatigue. Although no verbal instructions were provided, the rich sensory environment was designed to offer a passive but calming distraction from the clinical setting.
Participants in the control group will receive standard nursing care without any VR-based intervention. After data collection is completed, participants in the control group will be offered the opportunity to experience the VR content, but their responses will not be included in the study analysis.
- Being tested
- Virtual reality meditation, Virtual Reality Videos
- Keywords
- cancer, anxiety
- Medical subject headings
- Anxiety Disorders, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual reality meditationBehavioural
This intervention involves immersive virtual reality (VR)-based guided meditation sessions using MediboothVR, the first Turkish-language supported virtual reality meditation application developed in Türkiye. It is distinct from other VR interventions in the following ways:
Cultural and language adaptation: MediboothVR is fully available in Turkish, providing culturally relevant audio-guided content. This makes it more accessible and emotionally resonant for Turkish-speaking participants, unlike many VR applications designed in other languages.
Duration and consistency: The intervention is delivered over three consecutive days, with a different video used each day, each lasting approximately 10 minutes.
Technical delivery: The application is used exclusively via VR headsets, creating a fully immersive experience that eliminates visual and auditory distractions from the hospital environment.
Virtual Reality VideosBehavioural
This intervention involves the use of a virtual reality headset to present immersive 360-degree calming nature videos to participants. It is distinct from other video- or relaxation-based interventions in several key ways:
Delivery via VR headset: Unlike standard video-based relaxation interventions presented on screens or tablets, this method delivers video content in a fully immersive virtual reality environment, which blocks out external visual and auditory stimuli from the unit.
Non-guided and passive exposure: The video group receives no audio-guided instruction or meditation scripting, making it a purely visual and passive exposure intervention.
Cultural relevance and visual neutrality: The nature videos are non-verbal, visually neutral, and free of religious, symbolic, or emotionally provocative imagery, allowing them to be suitable for a diverse patient population.
| Study group | Role | What they receive |
|---|---|---|
| Virtual reality meditation group | Experimental | Participants in this group will use a virtual reality (VR) headset to complete a 10-minute meditation session on three consecutive days. A different meditation video will be used each day, and sessions will be held between 10:00 AM and 12:00 PM. The meditation sessions are provided through the "MediboothVR" application. This app is the first immersive virtual reality meditation tool developed in Türkiye and supports the Turkish language.
In MediboothVR, participants experience a 360-degree guided meditation in a virtual environment. Each video starts with a short environmental scene, followed by a visual journey to a meditation space where a guiding silhouette appears and leads the participant through the session. Each session lasts approximately 10 minutes. Receives: Behavioral: Virtual reality meditation |
| Virtual Reality Video Group | Active comparator | This group will use a VR headset on three consecutive days between 10:00 AM and 12:00 PM. Instead of meditation, participants will watch 360-degree nature videos. A different video (10 minute) will be shown each day. The purpose is to create a calming, immersive experience without guided meditation. Receives: Behavioral: Virtual Reality Videos |
| Control Group | No intervention | Participants in the control group will receive standard nursing care without any VR intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
State Anxiety
Change in State Anxiety Score
Anxiety levels will be measured using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI-S), a validated self-report tool.
The STAI-S consists of 20 items. Each item is rated on a 4-point Likert scale (1 = Not at all, 4 = Very much so). Total scores range from 20 to 80, with higher scores indicating greater anxiety.
Participants will complete the STAI-S before and after each VR session (or standard care, in the control group) on three consecutive days. This outcome will evaluate daily changes in state anxiety levels, and whether the intervention (VR meditation or VR video) leads to a significant reduction in anxiety compared to control.
Measured: Immediately Before and after each intervention session, on Day 1, Day 2, and Day 3 (total of 6 measurement points)
Secondary outcomes (7)
Trait Anxiety
Trait anxiety will be measured using the Trait Anxiety subscale of the State-Trait Anxiety Inventory (STAI-T), a validated self-report instrument.
The STAI-T consists of 20 items rated on a 4-point Likert scale (1 = Almost never, 4 = Almost always). Total scores range from 20 to 80, where higher scores indicate higher levels of trait (long-term) anxiety.
This outcome will assess changes in trait anxiety scores across three time points (baseline, post-intervention, and follow-up) to evaluate the immediate and sustained effects of virtual reality-based interventions compared to standard care. A reduction in scores will indicate a positive effect on long-term anxiety regulation.
Measured: Day 1 (baseline, before the first intervention),Day 3 (after the last intervention session), andDay 30 (follow-up assessment)
Virtual Reality Sickness
Virtual reality-induced discomfort will be assessed using the Virtual Reality Sickness Questionnaire (VRSQ), a standardized and validated instrument designed to measure symptoms such as dizziness, nausea, eye strain, and general discomfort during or after VR use.
The VRSQ consists of multiple items scored on a Likert-type scale. Higher total scores indicate greater levels of VR-induced discomfort.
This outcome will help evaluate the tolerability and usability of VR-based interventions in cancer patients receiving chemotherapy. It will also identify whether repeated exposure over three days influences the presence or intensity of VR sickness symptoms.
Note: This assessment is only applied to participants in the virtual reality meditation and VR video groups, and is not administered to the control group.
Measured: Immediately after each VR session on Day 1, Day 2, and Day 3
Participant Satisfaction with VR Intervention
Satisfaction with the virtual reality experience will be evaluated using a single-item visual analog scale ranging from 0 to 10, where:
0 = Not satisfied at all
10 = Extremely satisfied
This outcome will assess how participants perceived the comfort, usefulness, and overall satisfaction with the VR-based meditation or video intervention. Only participants in the intervention groups (VR meditation and VR video) will complete this measure.
Measured: Immediately after each VR session on Day 1, Day 2, and Day 3
Participant's Heart Rate
Vital signs will be measured immediately before and after each intervention session to assess the short-term physiological effects of the virtual reality experience. The following parameters will be recorded:
Heart rate (per minute)
Changes in these vital signs will be analyzed to determine whether the VR meditation or VR video sessions have any immediate impact on participants' physiological responses. The control group's measurements were taken at time points corresponding to those used in the intervention groups (e.g., 10 minutes after start for pre-test, 25th minute for post-test).
Measured: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Respiratory Rate
Vital signs will be measured immediately before and after each intervention session to assess the short-term physiological effects of the virtual reality experience. The following parameters will be recorded:
Respiratory rate (breaths per minute)
Changes in these vital signs will be analyzed to determine whether the VR meditation or VR video sessions have any immediate impact on participants' physiological responses. The control group's measurements were taken at time points corresponding to those used in the intervention groups (e.g., 10 minutes after start for pre-test, 25th minute for post-test).
Measured: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Blood Pressure
Vital signs will be measured immediately before and after each intervention session to assess the short-term physiological effects of the virtual reality experience. The following parameters will be recorded:
Blood pressure (mmHg)
Changes in these vital signs will be analyzed to determine whether the VR meditation or VR video sessions have any immediate impact on participants' physiological responses. The control group's measurements were taken at time points corresponding to those used in the intervention groups (e.g., 10 minutes after start for pre-test, 25th minute for post-test).
Measured: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Oxygen Saturation
Vital signs will be measured immediately before and after each intervention session to assess the short-term physiological effects of the virtual reality experience. The following parameters will be recorded:
Oxygen saturation (SpO₂, %)
Changes in these vital signs will be analyzed to determine whether the VR meditation or VR video sessions have any immediate impact on participants' physiological responses. The control group's measurements were taken at time points corresponding to those used in the intervention groups (e.g., 10 minutes after start for pre-test, 25th minute for post-test).
Measured: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2025
- Study start1 Apr 2024
- Primary completion1 Feb 2025
- Study completion1 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for AnxietyStudies of the same condition, open and under way.
- More trials run by Istanbul University - CerrahpasaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 89 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gulbeyaz Can, Istanbul University - Cerrahpasa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07088367
- Sponsor's protocol ID
- 2024-126
- Status last verified
- Aug 2024
- First submitted
- 12 Jun 2025
- Last updated
- 28 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared. Results will be reported at the group level in scientific publications.
Publications
Uslu A, Arslan S. The Effect of Using Virtual Reality Glasses on Anxiety and Fatigue in Women with Breast Cancer Receiving Adjuvant Chemotherapy: A Pretest-Posttest Randomized Controlled Study. Semin Oncol Nurs. 2023 Oct;39(5):151503. doi: 10.1016/j.soncn.2023.151503. Epub 2023 Sep 22.
PubMed 37741768Franklin, D. M., Silvestro, C., Carrillo, R. A., Yang, Y., Annadurai, D., Ganesan, S., Vasantham, D. S. J., Mettu, S., Patel, M., Patil, M. S., & Akurathi, N. D. (2023). The impact of meditation aided by VR technology as an emerging therapeutic to ease cancer related anxiety, stress, and fatigue. Frontiers in Virtual Reality, 4(July), 1-12. https://doi.org/10.3389/frvir.2023.1195196
Wu Y, Wang N, Zhang H, Sun X, Wang Y, Zhang Y. Effectiveness of Virtual Reality in Symptom Management of Cancer Patients: A Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2023 May;65(5):e467-e482. doi: 10.1016/j.jpainsymman.2023.01.023. Epub 2023 Feb 8.
PubMed 36758907Chow H, Hon J, Chua W, Chuan A. Effect of Virtual Reality Therapy in Reducing Pain and Anxiety for Cancer-Related Medical Procedures: A Systematic Narrative Review. J Pain Symptom Manage. 2021 Feb;61(2):384-394. doi: 10.1016/j.jpainsymman.2020.08.016. Epub 2020 Aug 19.
PubMed 32822755
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Virtual Reality Meditation on Anxiety Management in Cancer Patients Receiving Chemotherapy: A Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT07088367
- Acronym / sponsor ID
- 2024-126
- Keywords
- cancer, anxiety
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 89 participants (actual)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 1 Apr 2024 (actual)
- Primary completion
- 1 Feb 2025 (actual)
- Study completion
- 1 Mar 2025 (actual)
- First posted
- 28 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main questions this study aims to answer are:
Does VR meditation, delivered through virtual reality glasses and the MediboothVR application, effectively reduce anxiety in cancer patients during chemotherapy?
Is there a meaningful difference in anxiety reduction between the VR intervention groups and the control group?
Researchers will compare two intervention groups using VR glasses-one with guided meditation and one with calming video content-to a control group receiving standard care, to see if there are differences in anxiety levels.
Participants will:
Be randomly assigned to one of three groups
Attend their scheduled chemotherapy sessions
Depending on group assignment, either:
Use VR glasses with the MediboothVR meditation app for 10 minutes daily
Use VR glasses to watch calming 360-degree nature videos for 10 minutes daily
Receive standard care with no VR use
All participants will complete anxiety questionnaires and have their vital signs recorded before and after each session.
Detailed description
This clinical trial includes three parallel groups: a VR meditation group, a VR video group, and a control group.
Participants in the VR meditation group will receive a 10-minute virtual reality (VR) guided meditation session on three consecutive days, between 10:00 AM and 12:00 PM. The sessions will be delivered using virtual reality glasses and the MediboothVR application. A different meditation video will be used each day.
The MediboothVR application is the first immersive virtual reality meditation app developed in Türkiye and is also the first to support the Turkish language. It provides audio-guided meditation in a 360-degree artificial environment through virtual reality glasses. Each meditation video lasts approximately 10 minutes. Sessions begin with a short period for environmental observation, followed by a journey sequence that transports the user to a dedicated meditation area. A silhouette then appears and delivers the guided meditation experience through structured audio.
Participants in the VR video group will also use virtual reality glasses for 10 minutes each day, over three consecutive days, during the same time frame. Instead of meditation, they will watch 360-degree calming nature videos. A different video will be shown each day to support relaxation through immersive visual content.
These videos were selected to promote relaxation and included high-definition panoramic visuals such as forests, oceans, waterfalls, and mountain landscapes. Each day, a different video was used to maintain novelty and reduce visual fatigue. Although no verbal instructions were provided, the rich sensory environment was designed to offer a passive but calming distraction from the clinical setting.
Participants in the control group will receive standard nursing care without any VR-based intervention. After data collection is completed, participants in the control group will be offered the opportunity to experience the VR content, but their responses will not be included in the study analysis.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Virtual reality meditation group | Experimental | Behavioral: Virtual reality meditationParticipants in this group will use a virtual reality (VR) headset to complete a 10-minute meditation session on three consecutive days. A different meditation video will be used each day, and sessions will be held between 10:00 AM and 12:00 PM. The meditation sessions are provided through the "MediboothVR" application. This app is the first immersive virtual reality meditation tool developed in Türkiye and supports the Turkish language. In MediboothVR, participants experience a 360-degree guided meditation in a virtual environment. Each video starts with a short environmental scene, followed by a visual journey to a meditation space where a guiding silhouette appears and leads the participant through the session. Each session lasts approximately 10 minutes. |
| Virtual Reality Video Group | Active comparator | Behavioral: Virtual Reality VideosThis group will use a VR headset on three consecutive days between 10:00 AM and 12:00 PM. Instead of meditation, participants will watch 360-degree nature videos. A different video (10 minute) will be shown each day. The purpose is to create a calming, immersive experience without guided meditation. |
| Control Group | No intervention | –Participants in the control group will receive standard nursing care without any VR intervention. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Aged 18 years or older,
- Sufficient communication ability to respond to study questions,
- Receiving outpatient treatment for at least three consecutive days with a confirmed cancer diagnosis,
- Scoring 40 or above on the State Anxiety Inventory (STAI-S), indicating moderate or higher anxiety levels,
- Voluntarily agreeing to participate in the study.
Key exclusion criteria (14 listed)
- Inability to speak or understand Turkish,
- Being under contact isolation precautions,
- Presence of active eye discharge or visual impairment,
- History of seizures, epilepsy, or hypersensitivity to flashing lights,
- History of vertigo or motion sickness,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual reality meditationThis intervention involves immersive virtual reality (VR)-based guided meditation sessions using MediboothVR, the first Turkish-language supported virtual reality meditation application developed in Türkiye. It is distinct from other VR interventions in the following ways: Cultural and language adaptation: MediboothVR is fully available in Turkish, providing culturally relevant audio-guided content. This makes it more accessible and emotionally resonant for Turkish-speaking participants, unlike many VR applications designed in other languages. Duration and consistency: The intervention is delivered over three consecutive days, with a different video used each day, each lasting approximately 10 minutes. Technical delivery: The application is used exclusively via VR headsets, creating a fully immersive experience that eliminates visual and auditory distractions from the hospital environment. | Behavioural | Virtual reality meditation group |
| Virtual Reality VideosThis intervention involves the use of a virtual reality headset to present immersive 360-degree calming nature videos to participants. It is distinct from other video- or relaxation-based interventions in several key ways: Delivery via VR headset: Unlike standard video-based relaxation interventions presented on screens or tablets, this method delivers video content in a fully immersive virtual reality environment, which blocks out external visual and auditory stimuli from the unit. Non-guided and passive exposure: The video group receives no audio-guided instruction or meditation scripting, making it a purely visual and passive exposure intervention. Cultural relevance and visual neutrality: The nature videos are non-verbal, visually neutral, and free of religious, symbolic, or emotionally provocative imagery, allowing them to be suitable for a diverse patient population. | Behavioural | Virtual Reality Video Group |
Primary outcome
State Anxiety
Time frame: Immediately Before and after each intervention session, on Day 1, Day 2, and Day 3 (total of 6 measurement points)
Change in State Anxiety Score Anxiety levels will be measured using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI-S), a validated self-report tool. The STAI-S consists of 20 items. Each item is rated on a 4-point Likert scale (1 = Not at all, 4 = Very much so). Total scores range from 20 to 80, with higher scores indicating greater anxiety. Participants will complete the STAI-S before and after each VR session (or standard care, in the control group) on three consecutive days. This outcome will evaluate daily changes in state anxiety levels, and whether the intervention (VR meditation or VR video) leads to a significant reduction in anxiety compared to control.
7 secondary outcomes
Trait Anxiety
Time frame: Day 1 (baseline, before the first intervention),Day 3 (after the last intervention session), andDay 30 (follow-up assessment)
Virtual Reality Sickness
Time frame: Immediately after each VR session on Day 1, Day 2, and Day 3
Participant Satisfaction with VR Intervention
Time frame: Immediately after each VR session on Day 1, Day 2, and Day 3
Participant's Heart Rate
Time frame: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Respiratory Rate
Time frame: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Blood Pressure
Time frame: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Participant's Oxygen Saturation
Time frame: Immediately before and after each VR session on Day 1, Day 2, and Day 3.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2025.
- Background: PubMed 37741768Uslu A, Arslan S. The Effect of Using Virtual Reality Glasses on Anxiety and Fatigue in Women with Breast Cancer Receiving Adjuvant Chemotherapy: A Pretest-Posttest Randomized Controlled Study. Semin Oncol Nurs. 2023 Oct;39(5):151503. doi: 10.1016/j.soncn.2023.151503. Epub 2023 Sep 22.
- BackgroundFranklin, D. M., Silvestro, C., Carrillo, R. A., Yang, Y., Annadurai, D., Ganesan, S., Vasantham, D. S. J., Mettu, S., Patel, M., Patil, M. S., & Akurathi, N. D. (2023). The impact of meditation aided by VR technology as an emerging therapeutic to ease cancer related anxiety, stress, and fatigue. Frontiers in Virtual Reality, 4(July), 1-12. https://doi.org/10.3389/frvir.2023.1195196
- Background: PubMed 36758907Wu Y, Wang N, Zhang H, Sun X, Wang Y, Zhang Y. Effectiveness of Virtual Reality in Symptom Management of Cancer Patients: A Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2023 May;65(5):e467-e482. doi: 10.1016/j.jpainsymman.2023.01.023. Epub 2023 Feb 8.
- Background: PubMed 32822755Chow H, Hon J, Chua W, Chuan A. Effect of Virtual Reality Therapy in Reducing Pain and Anxiety for Cancer-Related Medical Procedures: A Systematic Narrative Review. J Pain Symptom Manage. 2021 Feb;61(2):384-394. doi: 10.1016/j.jpainsymman.2020.08.016. Epub 2020 Aug 19.
- MediboothVR applicationLink provided by the sponsor.
- Nature Video: Virture Forest WalkLink provided by the sponsor.
- Nature Video: Wetland Marsh Bird SoundsLink provided by the sponsor.
- Nature Video: Stones of the Skagit RiverLink provided by the sponsor.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared. Results will be reported at the group level in scientific publications.
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual reality meditation and Virtual Reality Videos in people with Anxiety and Cancer, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
State Anxiety (time frame: Immediately Before and after each intervention session, on Day 1, Day 2, and Day 3 (total of 6 measurement points)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07088367, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.